DYNAMO: a PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE‐REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA. (June 2017) - Zinzani, P.; Wagner‐Johnston, N.; Miller, C.; Ardeshna, K.; Tertreault, S.; Assouline, S.; Mayer, J.; Passamonti, F.; Lunin, S.; Pettitt, A.; Nagy, Z.; Tournilhac, O.; et al.